标题: Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy . f4 C5 A- M( j# ^* S, X期刊:Nature Medicine L; G. h/ Y: h& x5 {
volume4 V2 B1 S. P! f% w! m% K
25, - P( u! w# B) W3 n- u. k; |+ upages 5 }4 ]: O, ~5 w2 F' N. ^656–666(2019)